Asthma, Chronic Obstructive Pulmonary Disease, and Mortality in the U.S. Population

REFERENCES

• Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007 Sep 1; 370(9589):765–773.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance–United States, 1971–2000. Respir Care 2002 Oct; 47(10):1184–1199.
   PubMedGoogle Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001 Apr; 163(5):1256– 1276.
   PubMedGoogle Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 Jun; 23(6):932–946.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Kleinert S. COPD—a neglected disease. Lancet 2004 Aug 14-20; 364(9434):564–565.
   PubMed Web of Science ®Google Scholar
• Decramer M, Sibille Y. European conference on chronic respiratory disease. Lancet 2011 Jan 8; 377(9760):104–106.
   PubMed Web of Science ®Google Scholar
• WHO. World health statistics. http:\\www.whoint/whosis/whostat/EN_WHS08_Full.pdf (accessed Jan 31, 2011) 2008.
   Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 May; 59(5):469–478.
   PubMed Web of Science ®Google Scholar
• Akinbami LJ, Moorman JE, Liu X. Asthma Prevalence, Health Care Use and Mortality, United States: 2005–2009. 2011.
   Google Scholar
• Anandan C, Nurmatov U, van Schayck OC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010 Feb; 65(2):152–167.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003 Aug; 124(2):474–481.
   PubMed Web of Science ®Google Scholar
• Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008 Jul; 134(1):14–19.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009 Aug; 64(8):728–735.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999 Jan; 159(1):179–187.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 Sep 15; 176(6):532–555.
   PubMed Web of Science ®Google Scholar
• Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of the Ciba guest symposium. Thorax 1959(14):286–299.
   Google Scholar
• Viegi G, Matteelli G, Angino A, Scognamiglio A, Baldacci S, Soriano JB, The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 2004 Oct; 126(4):1093–1101.
   PubMed Web of Science ®Google Scholar
• Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009 Oct; 34(4):812–818.
   PubMed Web of Science ®Google Scholar
• Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm 2008 Mar; 14(2):176–185.
   PubMed Web of Science ®Google Scholar
• Meyer PA, Mannino DM, Redd SC, Olson DR. Characteristics of adults dying with COPD. Chest 2002 Dec; 122(6):2003–2008.
   PubMed Web of Science ®Google Scholar
• Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004 Jul; 24(1):122–128.
   PubMed Web of Science ®Google Scholar
• Panizza JA, James AL, Ryan G,de Klerk N, Finucane KE. Mortality and airflow obstruction in asthma: a 17-year follow-up study. Intern Med J 2006 Dec; 36(12):773–780.
   PubMed Web of Science ®Google Scholar
• Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004 Jul; 126(1):59–65.
   PubMed Web of Science ®Google Scholar
• Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010 Sep 4; 376(9743):803–813.
   PubMed Web of Science ®Google Scholar
• Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003 Oct 9; 349(15):1414-22.
   PubMed Web of Science ®Google Scholar
• Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis 1987 Apr; 135(4):794–799.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20: 819–825.
   PubMed Web of Science ®Google Scholar
• Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists. Respir Med 2006 Apr; 100(4):595–609.
   PubMed Web of Science ®Google Scholar
• Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. COPD 2007 Jun; 4(2):127–134.
   PubMedGoogle Scholar
• McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007 Dec; 132(6):1748–1755.
   PubMed Web of Science ®Google Scholar
• Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA. Cost and utilization of COPD and asthma among insured adults in the US. Curr Med Res Opin 2009 Jun; 25(6):1385–1392.
   PubMed Web of Science ®Google Scholar